View from the Thoraxcenter: EuroPCR 22 Late-breaking Science Wrap-Up

Published: 06 Jun 2022

  • Views:

    Views Icon 441
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Learn about the key take-home messages from EuroPCR 2022 with View from the Thoraxcenter hosts, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL).
In this succinct review video, they summarise the top late-breaking science trials and share their take on how the new data can be translated into practice.

Trials covered in detail include:
00:54: Descision-QFR: Heart Team decision-making based on angiography-derived FFR 
04:01: PROPHET-FFR: Safety and efficacy of post-PCI physiological assessment
06:52: LYTEN trial: Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprotheses
12:09: GREECE Trial: CT-guided invasive coronary angiography in patients with CABG
17:09: OPTIMIZE PRO: Impact of standardised TAVI technique and care pathway in the Optimize PRO study 
20:41: FORWARD PRO: Three-year outcomes following TAVI with a self-expanding valve with pericardial wrap 
22:52: JenaValve Trilogy for treatment of aortic regurgitation: worldwide first results
24:58: DISCO-RADIAL: DIStal vs. COnventional RADIAL access for coronary angiography and intervention